Innovotech Inc. (TSXV:IOT)
0.1600
-0.0250 (-13.51%)
At close: Mar 20, 2026
Innovotech Market Cap
Innovotech has a market cap or net worth of CAD 8.32 million as of March 20, 2026. Its market cap has increased by 125.10% in one year.
Market Cap
8.32M
Enterprise Value
7.36M
Revenue
4.46M
Ranking
n/a
PE Ratio
22.89
Stock Price
0.16
Market Cap Chart
Since November 30, 2004, Innovotech's market cap has increased from 2.20M to 8.32M, an increase of 278.50%. That is a compound annual growth rate of 6.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 8.32M | -39.62% |
| Dec 31, 2025 | 13.78M | 54.00% |
| Dec 27, 2024 | 8.95M | 206.64% |
| Dec 27, 2023 | 2.92M | -44.44% |
| Dec 29, 2022 | 5.25M | -28.95% |
| Dec 29, 2021 | 7.39M | -0.97% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Britannia Life Sciences | 15.41M |
| Hemostemix | 14.64M |
| Rapid Dose Therapeutics | 13.52M |
| Quantum BioPharma | 12.19M |
| PreveCeutical Medical | 11.96M |
| Pharmala Biotech Holdings | 11.44M |
| Marvel Biosciences | 10.08M |
| Glow Lifetech | 9.08M |